PortfoliosLab logo

Aerie Pharmaceuticals, Inc. (AERI)

Equity · Currency in USD · Last updated Nov 28, 2022

Company Info

ISINUS00771V1089
CUSIP00771V108
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Trading Data

Previous Close$15.25
Year Range$4.95 - $15.25
EMA (50)$14.73
EMA (200)$11.68
Average Volume$725.41K
Market Capitalization$753.62M

AERIShare Price Chart


Loading data...

AERIPerformance

The chart shows the growth of $10,000 invested in Aerie Pharmaceuticals, Inc. in Oct 2013 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $14,373 for a total return of roughly 43.73%. All prices are adjusted for splits and dividends.


0.00%50.00%100.00%150.00%200.00%JuneJulyAugustSeptemberOctoberNovember
194.41%
-3.11%
AERI (Aerie Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AERICompare to other instruments

Search for stocks, ETFs, and funds to compare with AERI

AERIReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M0.26%6.68%
6M135.70%0.75%
YTD117.24%-16.00%
1Y51.89%-14.78%
5Y-24.38%9.06%
10Y4.08%9.49%

AERIMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20224.84%12.77%9.64%-21.87%-27.14%44.79%-6.53%115.41%0.20%0.59%0.20%
202127.24%6.98%-2.83%-4.14%-4.90%-1.72%-1.44%-5.51%-23.54%-6.75%-4.99%-30.50%
2020-15.27%-14.55%-22.86%12.89%-7.94%5.20%-21.68%-4.84%7.00%-9.86%16.97%8.86%
201930.25%-0.74%1.78%-19.68%-4.53%-18.86%-26.67%-0.05%-11.27%15.45%-14.42%27.28%
2018-8.20%-6.75%6.06%-5.62%0.20%31.68%0.00%-9.18%0.33%-13.60%-24.99%-9.50%
201715.98%7.86%-4.22%-2.87%25.88%-5.23%3.33%5.62%-15.26%27.06%4.05%-7.00%
2016-32.07%1.81%-27.79%30.43%12.67%-1.51%-1.42%11.59%94.94%-11.90%11.73%1.88%
2015-4.21%0.57%11.45%-69.24%15.46%58.58%2.78%-12.84%12.21%28.58%20.30%-11.26%
20142.78%24.43%-7.75%-26.10%0.06%58.07%-28.42%-7.61%26.31%21.89%4.56%10.69%
2013-1.04%7.14%59.64%

AERISharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aerie Pharmaceuticals, Inc. Sharpe ratio is 0.66. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.50JuneJulyAugustSeptemberOctoberNovember
0.66
-0.60
AERI (Aerie Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AERIDividend History


Aerie Pharmaceuticals, Inc. doesn't pay dividends

AERIDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovember
-79.36%
-16.53%
AERI (Aerie Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AERIWorst Drawdowns

The table below shows the maximum drawdowns of the Aerie Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aerie Pharmaceuticals, Inc. is 93.30%, recorded on Jun 1, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-93.3%Jul 20, 2018974Jun 1, 2022
-73.52%Apr 24, 20156May 1, 2015350Sep 20, 2016356
-44.78%Mar 5, 201446May 8, 201433Jun 25, 201479
-39.55%Jun 27, 201429Aug 7, 201477Nov 25, 2014106
-26.56%Jan 16, 20148Jan 28, 201421Feb 27, 201429
-26.5%Oct 23, 2017138May 10, 201819Jun 7, 2018157
-23.32%Mar 8, 201750May 17, 20176May 25, 201756
-21.5%Jan 5, 201523Feb 5, 201530Mar 20, 201553
-19.82%Oct 11, 201619Nov 4, 20167Nov 15, 201626
-19.13%Sep 19, 20179Sep 29, 20178Oct 11, 201717

AERIVolatility Chart

Current Aerie Pharmaceuticals, Inc. volatility is 0.87%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%JuneJulyAugustSeptemberOctoberNovember
0.87%
30.58%
AERI (Aerie Pharmaceuticals, Inc.)
Benchmark (^GSPC)